As witnessed by the BIO 2005 meeting in Philadelphia last month, the globalization of the biotech industry beyond its U.S. roots has really taken flight. The company that perhaps best chronicles and tracks this trend is Ernst & Young in its annual report on biotechnology.
This report is usually released and previewed at the annual BIO meeting......Full article >>>
London Stock Exchange, the London AIM and the bourses in France, Germany, Switzerland, the Netherlands, Sweden, Denmark and Spain. Canada has two main exchanges: the Toronto Exchange and the Vancouver Exchange. Many Canadian companies seek to list in the U.S. to access capital there.
Another measurement for biotech globality would be the number of IPOs by region: